Patent details

EP3730608 Title: PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

Basic Information

Publication number:
EP3730608
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP201611795
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
French Title of Invention:
PROCÉDÉS DE PRODUCTION DE LYMPHOCYTES INFILTRANT LES TUMEURS ET LEURS UTILISATIONS EN IMMUNOTHÉRAPIE
German Title of Invention:
VORGÄNGE ZUR HERSTELLUNG VON TUMORINFILTRIERENDEN LYMPHOZYTEN UND DEREN VERWENDUNGEN IN DER IMMUNTHERAPIE
SPC Number:

Dates

Filing date:
05/01/2018
Grant date:
23/10/2024
EP Publication Date:
28/10/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/10/2024
EP B1 Publication Date:
23/10/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/01/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/10/2024
 
 

Name:
Iovance Biotherapeutics, Inc.
Address:
825 Industrial Road Suite 400, San Carlos, CA 94070, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
28/11/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WARDELL, Seth
Address:
United States (US)

2

Name:
BENDER, James
Address:
United States (US)

3

Name:
LOTZE, Michael, T.
Address:
United States (US)

Priority

1

Priority Number:
201762478506 P
Priority Date:
29/03/2017
Priority Country:
United States (US)

2

Priority Number:
201762539410 P
Priority Date:
31/07/2017
Priority Country:
United States (US)

3

Priority Number:
201762548306 P
Priority Date:
21/08/2017
Priority Country:
United States (US)

4

Priority Number:
201762554538 P
Priority Date:
05/09/2017
Priority Country:
United States (US)

5

Priority Number:
201762559374 P
Priority Date:
15/09/2017
Priority Country:
United States (US)

6

Priority Number:
201762567121 P
Priority Date:
02/10/2017
Priority Country:
United States (US)

7

Priority Number:
201762577655 P
Priority Date:
26/10/2017
Priority Country:
United States (US)

8

Priority Number:
201762582874 P
Priority Date:
07/11/2017
Priority Country:
United States (US)

9

Priority Number:
201762596374 P
Priority Date:
08/12/2017
Priority Country:
United States (US)

Classification

IPC classification:
C12N 5/0783; C12M 1/04;

Publication

European Patent Bulletin

Issue number:
202443
Publication date:
23/10/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/12/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
IP CENTRUM LIMITED
Filing date Document type Number of pages
28/11/2024 Power Of Attorney 1
28/11/2024 Outgoing Correspondence 1